Polli, Joseph Ryan
Chen, Ping
Bordeau, Brandon M.
Balthasar, Joseph P.
Article History
Received: 6 January 2022
Accepted: 5 March 2022
First Online: 25 March 2022
Declarations
:
: J.P.B. serves as the Director of the University at Buffalo Center for Protein Therapeutics, which is supported by an industry consortium. Through the consortium, J.P.B. has received research support, for work unrelated to this report, from Abbvie, Amgen, CSL-Behring, Eli Lilly, Genentech, GSK, Janssen, Merck, Roche, and Sanofi. During the course of this work, J.P.B. has received consulting fees from companies involved with the development of cancer therapies, including: Abbvie, Amgen, Eli Lilly, Merck, and Pfizer
: Protocols for animal experiments were approved by the Institutional Animal Use and Care Committee of the University at Buffalo (PHC44086Y).